Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Update on canine MSC markers.

Tryfonidou MA, Schumann S, Armeanu S, Harichandan A, Sivasubramaniyan K, Mollenhauer J, Bühring HJ.

Cytometry A. 2014 May;85(5):379-81. doi: 10.1002/cyto.a.22469. Epub 2014 Mar 27. No abstract available.

2.

Tumor biology influences the prognosis of nephroblastoma patients with primary pulmonary metastases: results from SIOP 93-01/GPOH and SIOP 2001/GPOH.

Warmann SW, Furtwängler R, Blumenstock G, Armeanu S, Nourkami N, Leuschner I, Schenk JP, Graf N, Fuchs J.

Ann Surg. 2011 Jul;254(1):155-62. doi: 10.1097/SLA.0b013e318222015e.

PMID:
21670612
3.

Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virus.

Mühlebach MD, Schaser T, Zimmermann M, Armeanu S, Hanschmann KM, Cattaneo R, Bitzer M, Lauer UM, Cichutek K, Buchholz CJ.

Cancer Res. 2010 Oct 1;70(19):7620-9. doi: 10.1158/0008-5472.CAN-09-4650. Epub 2010 Sep 21.

4.

Human precision-cut liver tumor slices as a tumor patient-individual predictive test system for oncolytic measles vaccine viruses.

Zimmermann M, Armeanu S, Smirnow I, Kupka S, Wagner S, Wehrmann M, Rots MG, Groothuis GM, Weiss TS, Königsrainer A, Gregor M, Bitzer M, Lauer UM.

Int J Oncol. 2009 May;34(5):1247-56.

PMID:
19360338
5.

Adenovirus-mediated cytosine deaminase/5-fluorocytosine suicide gene therapy of human hepatoblastoma in vitro.

Warmann SW, Armeanu S, Heigoldt H, Ruck P, Vonthein R, Heitmann H, Seitz G, Lemken ML, Bitzer M, Fuchs J, Lauer UM.

Pediatr Blood Cancer. 2009 Aug;53(2):145-51. doi: 10.1002/pbc.21956.

PMID:
19213079
6.

Establishing a novel single-copy primer-internal intron-spanning PCR (spiPCR) procedure for the direct detection of gene doping.

Beiter T, Zimmermann M, Fragasso A, Armeanu S, Lauer UM, Bitzer M, Su H, Young WL, Niess AM, Simon P.

Exerc Immunol Rev. 2008;14:73-85.

7.

In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.

Seitz G, Krause R, Fuchs J, Heitmann H, Armeanu S, Ruck P, Warmann SW.

Oncol Rep. 2008 Nov;20(5):1277-82.

PMID:
18949433
8.

Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma.

Armeanu S, Krusch M, Baltz KM, Weiss TS, Smirnow I, Steinle A, Lauer UM, Bitzer M, Salih HR.

Clin Cancer Res. 2008 Jun 1;14(11):3520-8. doi: 10.1158/1078-0432.CCR-07-4744.

9.

Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma.

Venturelli S, Armeanu S, Pathil A, Hsieh CJ, Weiss TS, Vonthein R, Wehrmann M, Gregor M, Lauer UM, Bitzer M.

Cancer. 2007 May 15;109(10):2132-41.

10.

In vitro photodynamic therapy of childhood rhabdomyosarcoma.

Seitz G, Warmann SW, Armeanu S, Heitmann H, Ruck P, Hoffman RM, Fuchs J, Wessels JT.

Int J Oncol. 2007 Mar;30(3):615-20.

PMID:
17273762
11.

Optimizing vector application for gene transfer into human hepatoblastoma cells.

Warmann SW, Armeanu S, Heitmann H, Ruck P, Seitz G, Wessels JT, Lemken ML, Lauer UM, Fuchs J, Bitzer M.

Pediatr Surg Int. 2006 Sep;22(9):733-42. Epub 2006 Jul 29.

PMID:
16896819
12.

HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.

Pathil A, Armeanu S, Venturelli S, Mascagni P, Weiss TS, Gregor M, Lauer UM, Bitzer M.

Hepatology. 2006 Mar;43(3):425-34.

PMID:
16583461
13.

Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model.

Graepler F, Lemken ML, Wybranietz WA, Schmidt U, Smirnow I, Gross CD, Spiegel M, Schenk A, Graf H, Lauer UA, Vonthein R, Gregor M, Armeanu S, Bitzer M, Lauer UM.

World J Gastroenterol. 2005 Nov 28;11(44):6910-9.

14.

In vitro gene targeting in human hepatoblastoma.

Warmann SW, Armeanu S, Frank H, Buck H, Graepler F, Lemken ML, Heitmann H, Seitz G, Lauer UM, Bitzer M, Fuchs J.

Pediatr Surg Int. 2006 Jan;22(1):16-23.

PMID:
16374644
15.

Severe impairment of dendritic cell allostimulatory activity by Sendai virus vectors is overcome by matrix protein gene deletion.

Armeanu S, Bitzer M, Smirnow I, Bossow S, Appel S, Ungerechts G, Bernloehr C, Neubert WJ, Lauer UM, Brossart P.

J Immunol. 2005 Oct 15;175(8):4971-80.

16.

Expression liver-directed genes by employing synthetic transcriptional control units.

Lemken ML, Wybranietz WA, Schmidt U, Graepler F, Armeanu S, Bitzer M, Lauer UM.

World J Gastroenterol. 2005 Sep 14;11(34):5295-302.

17.

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.

Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, Steinle A, Salih HR.

Cancer Res. 2005 Jul 15;65(14):6321-9.

18.

Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.

Armeanu S, Pathil A, Venturelli S, Mascagni P, Weiss TS, Göttlicher M, Gregor M, Lauer UM, Bitzer M.

J Hepatol. 2005 Feb;42(2):210-7.

PMID:
15664246
19.

Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer.

Fersis N, Smyczek-Gargya B, Armeanu S, Gagulic E, Pantic L, Relakis K, Friedrich M, Wallwiener D.

Eur J Gynaecol Oncol. 2004;25(1):45-50.

PMID:
15053061
20.

Efficient propagation of single gene deleted recombinant Sendai virus vectors.

Bernloehr C, Bossow S, Ungerechts G, Armeanu S, Neubert WJ, Lauer UM, Bitzer M.

Virus Res. 2004 Feb;99(2):193-7. Erratum in: Virus Res. 2004 May;101(2):205.

PMID:
14749185
21.

A young woman with splenic infarction.

Bitzer M, Armeanu S, Kröber SM, Horger MS, Erley CM.

Lancet. 2003 Nov 1;362(9394):1456. No abstract available.

PMID:
14602441
22.

Sendai virus vectors as an emerging negative-strand RNA viral vector system.

Bitzer M, Armeanu S, Lauer UM, Neubert WJ.

J Gene Med. 2003 Jul;5(7):543-53. Review.

PMID:
12825193
23.
24.

Cell cycle independent infection and gene transfer by recombinant Sendai viruses.

Armeanu S, Ungerechts G, Bernloehr C, Bossow S, Gregor M, Neubert WJ, Lauer UM, Bitzer M.

J Virol Methods. 2003 Mar;108(2):229-33.

PMID:
12609691
25.

Negative-strand RNA viral vectors: intravenous application of Sendai virus vectors for the systemic delivery of therapeutic genes.

Bitzer M, Ungerechts G, Bossow S, Graepler F, Sedlmeier R, Armeanu S, Bernloehr C, Spiegel M, Gross CD, Gregor M, Neubert WJ, Lauer UM.

Mol Ther. 2003 Feb;7(2):210-7.

26.

Vascular endothelial growth factor (VEGF165) and its influence on angiogenesis versus arteriogenesis in different vascular beds.

Nikol S, Pelisek J, Engelmann MG, Shimizu M, Fuchs A, Golda A, Armeanu S, Mekkaoui C, Rolland PH.

J Endovasc Ther. 2002 Dec;9(6):842-54.

PMID:
12546587
27.

Optimization of nonviral transfection: variables influencing liposome-mediated gene transfer in proliferating vs. quiescent cells in culture and in vivo using a porcine restenosis model.

Pelisek J, Engelmann MG, Golda A, Fuchs A, Armeanu S, Shimizu M, Mekkaoui C, Rolland PH, Nikol S.

J Mol Med (Berl). 2002 Nov;80(11):724-36. Epub 2002 Oct 24.

PMID:
12436349
28.

Caspase-8 and Apaf-1-independent caspase-9 activation in Sendai virus-infected cells.

Bitzer M, Armeanu S, Prinz F, Ungerechts G, Wybranietz W, Spiegel M, Bernlöhr C, Cecconi F, Gregor M, Neubert WJ, Schulze-Osthoff K, Lauer UM.

J Biol Chem. 2002 Aug 16;277(33):29817-24. Epub 2002 May 20.

29.
30.

Evaluation of endovascular techniques for creating a porcine femoral artery occlusion model.

Nikol S, Armeanu S, Engelmann MG, Pelisek J, Fuchs A, Zähringer C, Bartoli JM, Mesana T, Rolland PH.

J Endovasc Ther. 2001 Aug;8(4):401-7.

PMID:
11552732
31.

In vivo perivascular implantation of encapsulated packaging cells for prolonged retroviral gene transfer.

Armeanu S, Haessler I, Saller R, Engelmann MG, Heinemann F, Krausz E, Stange J, Mitzner S, Salmons B, Günzburg WH, Nikol S.

J Microencapsul. 2001 Jul-Aug;18(4):491-506.

PMID:
11428678
32.

Involvement of E-cadherin in the Development of Erythroid Cells; Subject Heading.

Armeanu S, MÜller CA, Klein G.

Hematology. 2000;5(4):307-316.

PMID:
11399629
33.

N-cadherin is developmentally regulated and functionally involved in early hematopoietic cell differentiation.

Puch S, Armeanu S, Kibler C, Johnson KR, Müller CA, Wheelock MJ, Klein G.

J Cell Sci. 2001 Apr;114(Pt 8):1567-77.

34.

Evaluation of beta-galactosidase activity in tissue in the presence of blood.

Pelisek J, Armeanu S, Nikol S.

J Vasc Res. 2000 Nov-Dec;37(6):585-93.

PMID:
11146413
35.

Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo.

Armeanu S, Pelisek J, Krausz E, Fuchs A, Groth D, Curth R, Keil O, Quilici J, Rolland PH, Reszka R, Nikol S.

Mol Ther. 2000 Apr;1(4):366-75.

36.

Prevention of Restenosis Using the Gene for Cecropin Complexed with DOCSPER Liposomes under Optimized Conditions.

Nikol S, Pelisek J, Engelmann MG, Rolland PH, Armeanu S.

Int J Angiol. 2000 Mar;9(2):87-94.

PMID:
10758203
37.

Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation.

Nikol S, Huehns TY, Krausz E, Armeanu S, Engelmann MG, Winder D, Salmons B, Hoefling B.

Gene Ther. 1999 May;6(5):737-48.

38.

The adhesion molecule E-cadherin and a surface antigen recognized by the antibody 9C4 are selectively expressed on erythroid cells of defined maturational stages.

Bühring HJ, Müller T, Herbst R, Cole S, Rappold I, Schuller W, Zhu X, Fritzsch U, Faul C, Armeanu S, Ullrich A, Klein G, Schmidt H.

Leukemia. 1996 Jan;10(1):106-16.

PMID:
8558914
39.

E-cadherin is functionally involved in the maturation of the erythroid lineage.

Armeanu S, Bühring HJ, Reuss-Borst M, Müller CA, Klein G.

J Cell Biol. 1995 Oct;131(1):243-9.

Supplemental Content

Loading ...
Support Center